WHO ICTRP trial

Prevention of ischemia/reperfusion injury by C1 esterase inhibitor (C1 INH)…

ISRCTN87180032 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN87180032
Public title Prevention of ischemia/reperfusion injury by C1 esterase inhibitor (C1 INH): Assessment of reperfusion injury in total knee arthroplasty
Scientific title Prevention of ischemia/reperfusion injury by C1 INH. Assessment of reperfusion injury in total knee arthroplasty: pilot study
Primary sponsor Bern University
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Observational
Phase Not Applicable
Countries Switzerland
Conditions Ischemia reperfusion injury after total knee arthroplasty Circulatory System Ischemia reperfusion injury after total knee arthroplasty
Interventions Total knee arthroplasty is an elective surgical procedure that takes place when medication and/or walking support instruments can no longer relieve severe knee pain. Using a tourniquet is important to produce a bloodless surgical field but…
Registration date Apr 11, 2016
Target size 60
Secondary IDs 201609_DCR_UNIBE_Rieben
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations